- Health & Pharmaceuticals›
- State of Health›
Cancer treatments: information provided to patients United Kingdom (UK) 2017
Cancer treatments: information provided to patients United Kingdom (UK) 2017
Share of information provided to patients undergoing radiotherapy or chemotherapy in the United Kingdom (UK) in 2017
by Conor Stewart,
last edited
Aug 17, 2018
This statistic displays the share of information provided to patients undergoing radiotherapy or chemotherapy in the United Kingdom (UK) in 2017, by the time of information provided. Of respondents undergoing chemotherapy, 84 percent were provided with all the information they needed before treatment started.
Share of information provided to patients undergoing radiotherapy or chemotherapy in the United Kingdom (UK) in 2017
Loading statistic...
| Radiotherapy | Chemotherapy | |
|---|---|---|
| Information provided before treatment | 86% | 84% |
| Information provided during treatment | 51% | 62% |
| Radiotherapy | Chemotherapy | |
|---|---|---|
| Information provided before treatment | 86% | 84% |
| Information provided during treatment | 51% | 62% |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Conor Stewart,
last edited
Aug 17, 2018
This statistic displays the share of information provided to patients undergoing radiotherapy or chemotherapy in the United Kingdom (UK) in 2017, by the time of information provided. Of respondents undergoing chemotherapy, 84 percent were provided with all the information they needed before treatment started.
- Show sources information
- Show publisher information
- Release date
- July 2018
- Region
- United Kingdom
- Survey time period
- April to June 2017
- Number of respondents
- 69,072 respondents
- Method of interview
- Omnibus survey
Free access to basic statistics
Source
- Show sources information
- Show publisher information
- Release date
- July 2018
More information
- Region
- United Kingdom
- Survey time period
- April to June 2017
- Number of respondents
- 69,072 respondents
- Method of interview
- Omnibus survey
Other statistics on the topic
Physicians, Hospitals & Pharmacies
Number of active physicians in the U.S. 2019 by specialty area
+State of Health
Deaths by cancer in the U.S. 1950-2016
Physicians, Hospitals & Pharmacies
Number of oncology specialty physicians in the U.S. 2016
+Pharmaceutical Products & Market
Global top pharmaceutical companies by oncology market share 2017 and 2024
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Oncology"
- Cancer facts
The most important statistics
- Leading causes of death worldwide in 2016 (in millions)Global death rate - leading causes 2016
- Number of cancer deaths worldwide in 2018, by major type of cancerCancer deaths worldwide by major type 2018
- Number of U.S. Americans with a history of cancer living between 2004 and 2019 (in millions)U.S. Americans with a history of cancer living 2004-2019
- Number of new cancer cases in the United States from 1999 to 2015*Number of new cancer cases in U.S. from 1999 to 2015
- Deaths by cancer in the U.S. from 1950 to 2016 (per 100,000 population)*Deaths by cancer in the U.S. 1950-2016
- Oncology market
The most important statistics
- Global oncology spending from 2010 to 2018 (in billion U.S. dollars)*Global oncology costs 2010-2018
- Projected growth and spending in the global oncology market between 2014 and 2023Expenditure and growth worldwide in oncology market 2014-2023
- Global oncology therapeutic spending growth in the period 2014-2018, by regionOncology medicine spending growth 2014-2018, by region
- Projected global oncology spending in 2023, by region (in billion U.S. dollars)Predicted oncology spending in 2023, by region
- Emerging cancer diagnostics market size worldwide in 2015 and 2023, by region (in billion U.S. dollars)Emerging cancer diagnostics market size by world region 2015 and 2023
- Growth of the U.S. oncology therapeutic market from 2013 to 2018, by segment (in billion U.S. dollars)Oncology therapeutic market growth U.S. 2013-2018, by segment
- Companies
The most important statistics
- Top 10 pharmaceutical companies based on global oncology revenue in 2017 and 2024 (in million U.S. dollars)Global oncology revenue by top ten pharmaceutical companies 2017 and 2024
- Top 10 pharmaceutical companies based on global oncology market share in 2017 and 2024Global top pharmaceutical companies by oncology market share 2017 and 2024
- Revenue distribution of Roche's Pharmaceuticals division in 2017 and 2018, by therapeutic areaRevenue share of Roche's Pharmaceuticals division by therapy area 2017-2018
- Revenues of biotech company Celgene's top products from 2013 to 2018 (in million U.S. dollars)Celgene's top product revenues 2013-2018
- Bristol-Myers Squibb's top products based on revenue from 2015 to 2018 (in million U.S. dollars)Bristol-Myers Squibb's top products based on revenue 2015-2018
- Venture investments in oncology companies in the U.S. from 2006 to 2018 (in million U.S. dollars)U.S. venture investments in oncology companies 2006-2018
- Amount raised through initial public offerings (IPOs) from oncology companies in the U.S. from 2006 to 2018 (in million U.S. dollars)*U.S. oncology company IPO money raised 2006-2018
- Cancer drugs
The most important statistics
- Top 5 oncology products worldwide based on revenue in 2017 and 2024 (in million U.S. dollars)*Top 5 worldwide oncology products by revenue 2017 and 2024
- Top 5 oncology products worldwide by market share in 2017 and 2024Top 5 worldwide oncology products by market share 2017 and 2024
- Availability of new cancer drugs launched in 2013-2017 in selected countries as of 2018Availability of new cancer drugs by country as of 2018
- Leading U.S. oncology brands based on revenue in 2016 (in million U.S. dollars)Top U.S. oncology products by revenue in 2016
- Number of oncology drugs by treatment cost and number of patients in the U.S. as of 2017Number of cancer drugs by cost and number of patients U.S. 2017
- Research and development
The most important statistics
- Distribution of FDA breakthrough therapy requests by therapy area in 2018FDA on breakthrough therapy requests by therapy area 2018
- Distribution of FDA breakthrough therapy requests granted by therapy area in 2018FDA on breakthrough therapy requests granted by therapy area 2018
- Distribution of late phase oncology pipeline in 2008 and 2018, by typeDistribution of late phase oncology pipeline 2008 vs. 2018 by type
- Number of cancer drugs in development in the United States in select years between 2005 and 2018Number of cancer drugs in development in the U.S. 2005-2018
- Time between R&D start and approval of selected cancer drugs on the market as of 2017 (in years) Time from R&D start to approval of select cancer drugs 2017
- Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars)Total R&D costs including costs of capital for select cancer drugs 2017
- Immuno-oncology
The most important statistics
- Top 10 mechanisms of action in R&D pipeline drugs worldwide by number of active compounds in 2019*Worldwide top drug producing mechanisms of action by number of active compounds 2019
- Distribution of the immuno-oncology pipeline worldwide as of 2018, by mechanism of actionDistribution of the immuno-oncology pipeline worldwide 2018, by mechanism of action
- Global cancer immunotherapy market in 2016 and projection for 2022 (in billion U.S. dollars)Global cancer immunotherapy market size 2016 and 2022 forecast
- Market share forecast for top immuno-oncology companies worldwide in 2021*Global cancer immunotherapy sales share by type 2021 forecast
- Top 10 immuno-oncology collaborations worldwide based on value as of 2018 (in billion U.S. dollars)Leading cancer immunotherapy collaborations worldwide by value 2018
- Treatment types
The most important statistics
- Distribution of treatment types for female breast cancer in the U.S. in 2016, by stageDistribution of treatment types for female breast cancer by stage 2016
- Distribution of treatment types for prostate cancer in the U.S. in 2010-2012Distribution of treatment types for prostate cancer 2010-2012
- Distribution of treatment types for colon cancer in the U.S. in 2016, by stageDistribution of treatment types for colon cancer by stage 2016
- Distribution of treatment types for lung cancer in the U.S. in 2016*Distribution of treatment types for lung cancer in the U.S. 2016
- Distribution of treatment types for non-Hodgkin lymphoma in the U.S. in 2013Distribution of treatment types for non-Hodgkin lymphoma 2013
- Physicians and patients
The most important statistics
- Number of oncologists per one million people in select countries as of 2018Number of oncologists per one million people by select country 2018
- Number of active physicians in the U.S. in 2019, by specialty areaNumber of active physicians in the U.S. 2019 by specialty area
- Number of U.S. physicians in oncology specialties in 2016Number of oncology specialty physicians in the U.S. 2016
- Hours per week that oncologists in the U.S. spend seeing patients as of 2018Number of hours U.S. oncologists spend a week seeing patients 2018
- Minutes that oncologists in the U.S. spend with each patient as of 2018Number of minutes U.S. oncologists spend with each patient 2018
- Medication usage among patients with cancer in selected countries as of 2018*Cancer patients using medication in select countries 2018
- Lifestyle among patients with cancer in selected countries as of 2018*Cancer sufferers based on lifestyle habits by select country 2018
- Average length of stay in U.S. hospitals per inpatient cancer cases from 2008 to 2017 (in days)Inpatient average length of stay in U.S. hospitals by cancer type 2008-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Information provided about operations for cancer United Kingdom (UK) 2017
- Information provided to support cancer patients in the United Kingdom (UK) 2017
- Visits to chemotherapy daycare in French healthcare facilities 2015
- Share of Americans who underwent cancer/oncology treatment 2018, by age
- Chemotherapy sessions in healthcare facilities in France 2015
- Chemotherapy pre-medications administered in France 2012
- Sense of information of the French regarding cancer 2016
- Support for medical marijuana legalization for select uses 2018, by age
- Treatment for malignant chronic disease among Chinese high-net-worth individuals 2014
- Treatment for complex chronic diseases of Chinese high-net-worth individuals 2014
- Treatment of chronic diseases of Chinese high-net-worth individuals 2014, by facility
- Willingness to travel for medical treatment in another EU-28 country in 2014
- Willingness to travel for medical treatment in another EU-28 country in 2014, by age
- Reasons to travel for medical treatment in another EU-28 country in 2014
- Prior authorization to have medical treatment in another EU-28 country in 2014
- Colon cancer cases in England 2017 by age and gender
- Bladder cancer cases in England 2017, by age and gender
- Ovarian cancer mortality per incidence ratio in England 2016, by region
Statistics on "Oncology"
- Leading causes of death worldwide in 2016 (in millions)
- Number of cancer deaths worldwide in 2018, by major type of cancer
- Number of U.S. Americans with a history of cancer living between 2004 and 2019 (in millions)
- Number of new cancer cases in the United States from 1999 to 2015*
- Deaths by cancer in the U.S. from 1950 to 2016 (per 100,000 population)*
- Global oncology spending from 2010 to 2018 (in billion U.S. dollars)*
- Projected growth and spending in the global oncology market between 2014 and 2023
- Global oncology therapeutic spending growth in the period 2014-2018, by region
- Projected global oncology spending in 2023, by region (in billion U.S. dollars)
- Emerging cancer diagnostics market size worldwide in 2015 and 2023, by region (in billion U.S. dollars)
- Growth of the U.S. oncology therapeutic market from 2013 to 2018, by segment (in billion U.S. dollars)
- Top 10 pharmaceutical companies based on global oncology revenue in 2017 and 2024 (in million U.S. dollars)
- Top 10 pharmaceutical companies based on global oncology market share in 2017 and 2024
- Revenue distribution of Roche's Pharmaceuticals division in 2017 and 2018, by therapeutic area
- Revenues of biotech company Celgene's top products from 2013 to 2018 (in million U.S. dollars)
- Bristol-Myers Squibb's top products based on revenue from 2015 to 2018 (in million U.S. dollars)
- Venture investments in oncology companies in the U.S. from 2006 to 2018 (in million U.S. dollars)
- Amount raised through initial public offerings (IPOs) from oncology companies in the U.S. from 2006 to 2018 (in million U.S. dollars)*
- Top 5 oncology products worldwide based on revenue in 2017 and 2024 (in million U.S. dollars)*
- Top 5 oncology products worldwide by market share in 2017 and 2024
- Availability of new cancer drugs launched in 2013-2017 in selected countries as of 2018
- Leading U.S. oncology brands based on revenue in 2016 (in million U.S. dollars)
- Number of oncology drugs by treatment cost and number of patients in the U.S. as of 2017
- Distribution of FDA breakthrough therapy requests by therapy area in 2018
- Distribution of FDA breakthrough therapy requests granted by therapy area in 2018
- Distribution of late phase oncology pipeline in 2008 and 2018, by type
- Number of cancer drugs in development in the United States in select years between 2005 and 2018
- Time between R&D start and approval of selected cancer drugs on the market as of 2017 (in years)
- Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars)
- Top 10 mechanisms of action in R&D pipeline drugs worldwide by number of active compounds in 2019*
- Distribution of the immuno-oncology pipeline worldwide as of 2018, by mechanism of action
- Global cancer immunotherapy market in 2016 and projection for 2022 (in billion U.S. dollars)
- Market share forecast for top immuno-oncology companies worldwide in 2021*
- Top 10 immuno-oncology collaborations worldwide based on value as of 2018 (in billion U.S. dollars)
- Distribution of treatment types for female breast cancer in the U.S. in 2016, by stage
- Distribution of treatment types for prostate cancer in the U.S. in 2010-2012
- Distribution of treatment types for colon cancer in the U.S. in 2016, by stage
- Distribution of treatment types for lung cancer in the U.S. in 2016*
- Distribution of treatment types for non-Hodgkin lymphoma in the U.S. in 2013
- Number of oncologists per one million people in select countries as of 2018
- Number of active physicians in the U.S. in 2019, by specialty area
- Number of U.S. physicians in oncology specialties in 2016
- Hours per week that oncologists in the U.S. spend seeing patients as of 2018
- Minutes that oncologists in the U.S. spend with each patient as of 2018
- Medication usage among patients with cancer in selected countries as of 2018*
- Lifestyle among patients with cancer in selected countries as of 2018*
- Average length of stay in U.S. hospitals per inpatient cancer cases from 2008 to 2017 (in days)
- Percentage of patients whose tumors are driven by certain genetic mutations as of 2016, by cancer type
- Share of information provided about operations for cancer in the United Kingdom (UK) in 2017
- Share of information offered to support cancer patients in the United Kingdom (UK) in 2017
- Number of ambulatory chemotherapy sessions in France in 2015, by facility sector
- Share of Americans who received cancer/oncology treatment in the last 3 years in 2018, by age
- Number of outpatient chemotherapy sessions in France in 2015, by type of health facility
- Number of chemotherapy pre-medications administered in France in 2012, by type of health facility
- Do you feel well informed about cancer in general?
- Percentage of U.S. adults that supported medical cannabis use among cancer patients as of 2018, by age*
- Breakdown of malignant chronic disease treatment among Chinese high-net-worth individuals as of 2014, by facility
- Breakdown of complex chronic disease treatment among Chinese high-net-worth individuals as of 2014, by facility
- Breakdown of chronic disease treatment among Chinese high-net-worth individuals as of 2014, by facility
- Would you be willing to travel to another EU country to receive medical treatment?
- Would you be willing to travel to another EU country to receive medical treatment?
- For which of the following reasons would you be willing to travel to another EU country to receive medical treatment?
- If you were travelling to have medical treatment in another EU country, do you think you would need to get prior authorization from your health authority or health insurer to have those treatments reimbursed?*
- Registrations of newly diagnosed cases of colon cancer in England in 2017, by age group*
- Registrations of newly diagnosed cases of bladder cancer in England in 2017, by age group and gender*
- Rate of mortality to ovarian cancer incidence in England in 2016, by region*
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month*
| |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.